The well researched article by Martin and Bonomo1 may provide the Australian government with the kind of safety and efficacy data mandatory for all new drugs marketed to human populations. However, the authors did not discuss the efficacy of cannabis compared with that of accepted safe medicines; this applies to most of the indications that have been alleged but not proven for cannabis, including pain, spasticity, anticonvulsant action, weight gain and antiglaucoma agents.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
